| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/26/1995 | WO1995013826A1 Preventive and remedy for allergic disease |
| 05/26/1995 | WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | CA2176507A1 Endothelin-converting enzyme |
| 05/26/1995 | CA2153482A1 Delivery of gene products via mesangial cells |
| 05/24/1995 | EP0654273A1 Pharmaceutical product and method for treatment |
| 05/24/1995 | EP0654089A1 Recombinant equine herpesviruses |
| 05/24/1995 | EP0654086A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/24/1995 | EP0654083A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 05/24/1995 | EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 05/24/1995 | EP0654043A1 Method for preparing a metal-radionuclide-labelled protein |
| 05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
| 05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
| 05/24/1995 | EP0548194B1 Monoclonal antibody active against the interleukin-2 receptor |
| 05/24/1995 | EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
| 05/23/1995 | US5417986 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
| 05/23/1995 | US5417971 Vaccines for Actinobacillus pleuropneumoniae |
| 05/23/1995 | CA1335661C Non-reverting shigella live vaccines |
| 05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
| 05/23/1995 | CA1335654C Monoclonal antibodies capable of recognizing gangliosides go__ and gt |
| 05/23/1995 | CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1995 | WO1995013370A1 Haemophilus transferrin receptor genes |
| 05/18/1995 | WO1995013363A1 Hematopoietic stem cells from swine cord blood and uses thereof |
| 05/18/1995 | WO1995013297A2 Improved immunogenic compositions against human gastrin 17 |
| 05/18/1995 | WO1995013294A1 Cytokines from natural killer or t cells |
| 05/18/1995 | WO1995013094A1 Treatment of bacterially-induced inflammatory diseases |
| 05/18/1995 | WO1995013093A1 Treatment of a patient prior to transplantation |
| 05/18/1995 | WO1995013092A1 REESTABLISHMENT OF IFN-η INDUCIBILITY OR CONSTITUTIVE EXPRESSION OF MHC CLASS II IN TUMOR CELLS |
| 05/18/1995 | WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 05/18/1995 | DE4326821A1 New cancer vaccine based on autologous, transfected tumour cells |
| 05/18/1995 | DE3744826C2 New hybrid protein corresp. to HTLV-3 env and gag determinants |
| 05/18/1995 | CA2176257A1 Reestablishment of ifn-.gamma. inducibility or constitutive expression of mhc class ii in tumor cells |
| 05/18/1995 | CA2176237A1 Treatment of bacterially-induced inflammatory diseases |
| 05/18/1995 | CA2176115A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 05/18/1995 | CA2176114A1 Cytokines from natural killer or t cells |
| 05/17/1995 | EP0653489A1 Coccidiosis poultry vaccin |
| 05/17/1995 | EP0652967A1 Self-assembling replication defective hybrid virus particles |
| 05/17/1995 | EP0652966A1 Method of increasing expression of viral proteins |
| 05/17/1995 | EP0652962A1 Expression of recombinant fusion proteins in attenuated bacteria |
| 05/17/1995 | EP0652956A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 05/17/1995 | EP0652953A1 Morphogenic protein soluble complex and composition thereof |
| 05/17/1995 | EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 05/17/1995 | EP0652896A1 Peptide compounds |
| 05/17/1995 | EP0652891A1 T-cell membrane inducing factors |
| 05/17/1995 | EP0652775A1 Targeting of liposomes to the blood-brain barrier |
| 05/17/1995 | EP0652772A1 Herpesvirus vaccines |
| 05/17/1995 | EP0652771A1 Tetanus vaccine production |
| 05/17/1995 | EP0652764A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 05/17/1995 | EP0652758A1 Diphtheria toxin vaccines |
| 05/17/1995 | EP0395634B1 Htlv-i peptide antigen and assay |
| 05/17/1995 | EP0274482B1 Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 05/17/1995 | CN1102591A "Sanmiao" compound mixture and its prescription |
| 05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
| 05/16/1995 | US5416201 DNAs that code for mouse interleuken 4 |
| 05/16/1995 | US5416070 Composition for macrophage activation |
| 05/16/1995 | US5416021 Fibronectin binding protein-encoding DNA |
| 05/16/1995 | US5415995 Diagnostic peptides of human papilloma virus |
| 05/16/1995 | US5415859 Production and use of antheimintic agents and protective antigens |
| 05/16/1995 | CA1335571C Vaccine preparation comprising a bacterial toxin adjuvant |
| 05/16/1995 | CA1335569C Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals |
| 05/13/1995 | CA2135547A1 Coccidiosis poultry vaccine |
| 05/11/1995 | WO1995012682A2 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/11/1995 | WO1995012681A1 Methods relating to ir-95 |
| 05/11/1995 | WO1995012679A1 Anti-helminth vaccines |
| 05/11/1995 | WO1995012677A2 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | WO1995012676A1 Chimeric proteins comprising borrelia polypeptides: uses therefor |
| 05/11/1995 | WO1995012673A1 Receptor on the surface of activated t-cells: acts-4 |
| 05/11/1995 | WO1995012671A1 Helminth parasite antigen with aminopeptidase-like activity |
| 05/11/1995 | WO1995012670A1 Opioid receptor: compositions and methods |
| 05/11/1995 | WO1995012412A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | WO1995012411A1 Vaccine and method for treatment of chlamydial infections |
| 05/11/1995 | WO1995012410A1 Vaccine design and production |
| 05/11/1995 | WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | CA2552499A1 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | CA2175922A1 Methods relating to ir-95 |
| 05/11/1995 | CA2175708A1 Vaccine design and production |
| 05/11/1995 | CA2175692A1 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | CA2175454A1 Helminth parasite antigen with aminopeptidase-like activity |
| 05/11/1995 | CA2175214A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | CA2175081A1 Vaccine and method for treatment of chlamydial infections |
| 05/11/1995 | CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | CA2172815A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/11/1995 | CA2135330A1 Live vaccine vectors based on mycoplasma gallisepticum and nucleic acid probes therefrom |
| 05/10/1995 | EP0652287A2 Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease |
| 05/10/1995 | EP0652232A1 P53as protein and antibody therefor |
| 05/10/1995 | EP0651826A1 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 05/10/1995 | EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 05/10/1995 | EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 05/10/1995 | EP0651806A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/10/1995 | EP0651805A1 Method of intracellular binding of target molecules |
| 05/10/1995 | EP0651800A1 Basophil granule proteins |
| 05/10/1995 | EP0651798A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 05/10/1995 | EP0651797A1 A method for generation of antibodies to cell surface molecules |
| 05/10/1995 | EP0651790A1 Type-c rotavirus cultures and uses therefor |
| 05/10/1995 | EP0651789A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 05/10/1995 | EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 05/10/1995 | EP0651656A1 Use of gm-csf as a vaccine adjuvant |
| 05/10/1995 | EP0651653A1 p53 VACCINE |